Cadara
Cadara Appoints Marina Aslanyan Chief Executive Officer
Cadara announced a leadership change on August 25, 2026. Cadara, formerly National Care Systems, appointed former SmartLinx CEO Marina Aslanyan to lead the post-acute care technology company’s strategy, product innovation, customer success, and commercial growth.
What changed
Marina Aslanyan was named Chief Executive Officer.
- Leader: Marina Aslanyan
- Role: Chief Executive Officer
- Effective: Not specified in the announcement
- Announcement date: August 25, 2026
Leadership background
Aslanyan brings more than 25 years of executive leadership experience in enterprise software and healthcare technology, the company said. Most recently she served as Chief Executive Officer of SmartLinx and previously was president of Altitude Strategic Consulting. Earlier executive roles included positions at Sparta Systems, Andersen Consulting, PricewaterhouseCoopers, EDS, and Barr Laboratories.
The mandate
Cadara said Aslanyan will lead its long-term strategy, product innovation, customer success, and commercial growth while advancing its mission of helping post-acute organizations optimize operational and financial outcomes. The company said it is accelerating investments in artificial intelligence, organizational growth, and next-generation technologies to support the evolving needs of post-acute care.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Cadara leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


